The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Prolastin1000mg, powder and solvent for solution for infusion



Grifols Deutschland GmbHPA1405/002/001

Main Information

Trade NameProlastin1000mg, powder and solvent for solution for infusion
Active SubstancesAlpha-1-proteinase inhibitor
Dosage FormPowder and solvent for solution for infusion
Licence HolderGrifols Deutschland GmbH
Licence NumberPA1405/002/001

Group Information

ATC CodeB02AB Proteinase inhibitors
B02AB02 alfa1 antitrypsin

Status

License statusAuthorised
Licence Issued05/01/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceBatches of blood product marketed in Ireland shall be subject to control authority batch release in accordance with Article 114.2 of Directive 2001/83/EC as amended.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back